Financial results - MABUSMED S.R.L.

Financial Summary - Mabusmed S.r.l.
Unique identification code: 31084974
Registration number: J05/546/2015
Nace: 4110
Sales - Ron
-
Net Profit - Ron
-11.955
Employee
1
The most important financial indicators for the company Mabusmed S.r.l. - Unique Identification Number 31084974: sales in 2023 was - euro, registering a net profit of -11.955 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Dezvoltare (promovare) imobiliara having the NACE code 4110.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Mabusmed S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 33.895 0 0 0 193.191 211.346 192.625 0 90.382 0
Total Income - EUR 62.902 4.760 2.343 1.576 193.872 232.904 199.956 5.962 101.033 25.091
Total Expenses - EUR 48.227 6.828 12.040 1.150 1.356 53.536 42.659 32.585 20.509 37.046
Gross Profit/Loss - EUR 14.675 -2.068 -9.698 426 192.516 179.368 157.297 -26.623 80.524 -11.955
Net Profit/Loss - EUR 12.862 -2.083 -9.704 408 190.583 177.255 155.371 -26.623 79.620 -11.955
Employees 0 0 0 0 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.

Check the financial reports for the company - Mabusmed S.r.l.

Rating financiar

Financial Rating -
Mabusmed S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Mabusmed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Mabusmed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Mabusmed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Mabusmed S.r.l. - CUI 31084974

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 9.573 9.654 41 40 39 1.841.228 1.806.323 1.766.266 1.771.746 1.766.373
Current Assets 91.341 90.698 90.343 55.728 208.326 231.249 247.685 77.494 81.214 85.037
Inventories 0 0 0 0 0 0 0 0 0 1
Receivables 91.239 90.845 90.247 25.439 198.292 105.833 243.704 66.697 67.064 67.096
Cash 102 -147 96 30.289 10.034 125.416 3.980 10.797 14.150 17.940
Shareholders Funds 61.825 60.258 85 492 191.065 364.704 513.161 475.159 556.253 542.611
Social Capital 223 225 223 219 215 295 289 283 284 283
Debts 39.089 40.094 90.298 55.276 17.300 1.707.772 1.540.846 1.368.600 1.296.706 1.308.799
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4110 - 4110"
CAEN Financial Year 4110
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 85.037 euro in 2023 which includes Inventories of 1 euro, Receivables of 67.096 euro and cash availability of 17.940 euro.
The company's Equity was valued at 542.611 euro, while total Liabilities amounted to 1.308.799 euro. Equity decreased by -11.955 euro, from 556.253 euro in 2022, to 542.611 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Mabusmed S.r.l.

Comments - Mabusmed S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.